Advancing CRISPR: Caszyme Collaborates with Integra Therapeutics
After years of collaboration, Caszyme, a developer of CRISPR gene-editing technologies, has entered into a partnership with Barcelona-based Integra Therapeutics. The agreement focuses on incorporating Caszyme's Cas12l genome editor into Integra’s FiCAT …